SCHEMBL10291744

SCHEMBL10291744

Bc1ccc(C2CCN(C(=O)CC(C)C)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 3/20 0.49
▸ PTPN1 P18031 1/20 0.49
▸ CYP2C9 P11712 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ POLB P06746 3/20 0.45
▸ KCNH2 Q12809 1/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ SLC9A1 P19634 1/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ NAMPT P43490 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10291725 0.86 POLB (0.62) CCR1PTPN1CYP2C9CYP2C19KDM4E
SCHEMBL10291735 0.86 CCR1 (0.65) CCR1POLBKCNH2
SCHEMBL14434315 0.86 POLB (0.59) CCR1PTPN1CYP2C9CYP2C19KDM4E
SCHEMBL10291634 0.74 CCR1 (0.60) CCR1KCNH2
SCHEMBL25443739 0.74 SLC9A1 (0.46) CCR1PTPN1CYP2C9CYP2C19KDM4E
SCHEMBL14749038 0.74 KDM4E (0.50) PTPN1CYP2C9CYP2C19KDM4EPOLB
SCHEMBL14672010 0.73 HRH3 (0.56) CCR1CYP2C9CYP2C19KDM4EPOLB
SCHEMBL15686707 0.72 EPHX2 (0.60) CCR1KCNH2HRH3ALDH1A1EPHX2
SCHEMBL12321681 0.71 NAMPT (0.60) PTPN1KDM4EALDH1A1NAMPT
SCHEMBL15840473 0.71 ADAMTS5 (0.58) POLBKCNH2HRH3ALDH1A1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2471774-A1 Piperidinyl derivatives as modulators of chemokine receptor activity Bristol-Myers Squibb Company (US) 2012-07-04 — — EP disclosed
Send feedback